Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Aug;36(2):206–214. doi: 10.1038/bjc.1977.179

Effects of cytotoxic agents on TdR incorporation and growth delay in human colonic tumour xenografts.

P J Houghton, J A Houghton, D M Taylor
PMCID: PMC2025473  PMID: 911658

Abstract

The relationship between the utilization of 3H-thymidine in situ ([3H]-TdR fractional incorporation or TFI) and tumour growth delay after treatment with various cytotoxic agents has been examined. It is shown that (a) it is not possible to predict tumour growth delay, or to select the most effective agent, from changes in TFI 1 day after treatment; (b) there is a good correlation between tumour growth delay and the time for recovery of TFI to the pretreatment level; (c) there is a relationship within a tumour line between the depression of TFI 4 days after treatment and growth dealy induced by the same treatment. This relationship appears to be independent of the mechanism by which the agent exerts its cytotoxic effect.

Full text

PDF
206

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Connors T. A., Phillips B. J. Commentary: screening for anti-cancer agents; the relative merits of in vitro and in vovo techniques. Biochem Pharmacol. 1975 Dec 15;24(24):2217–2224. doi: 10.1016/0006-2952(75)90258-0. [DOI] [PubMed] [Google Scholar]
  2. Izsak F. C., Eylan E., Gazith A., Shapiro J., Naharin S., Raanani C. Growth inhibiting effects of cytotoxic agents on human tumor and tumor-bearing normal tissue in vitro. Eur J Cancer. 1971 Feb;7(1):33–39. doi: 10.1016/0014-2964(71)90092-2. [DOI] [PubMed] [Google Scholar]
  3. Livingston R. B., Ambus U., George S. L., Freireich E. J., Hart J. S. In vitro determination of thymidine-3H labeling index in human solid tumors. Cancer Res. 1974 Jun;34(6):1376–1380. [PubMed] [Google Scholar]
  4. Moertel C. G. Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma. Br J Cancer. 1976 Sep;34(3):325–334. [PMC free article] [PubMed] [Google Scholar]
  5. Murphy W. K., Livingston R. B., Ruiz V. G., Gercovich F. G., George S. L., Hart J. S., Freireich E. J. Serial labeling index determination as a predictor of response in human solid tumors. Cancer Res. 1975 Jun;35(6):1438–1444. [PubMed] [Google Scholar]
  6. Simpson-Herren L., Sanford A. H., Holmquist J. P. Cell population kinetics of transplanted and metastatic Lewis lung carcinoma. Cell Tissue Kinet. 1974 Jul;7(4):349–361. doi: 10.1111/j.1365-2184.1974.tb00417.x. [DOI] [PubMed] [Google Scholar]
  7. Sky-Peck H. H. Effects of chemotherapy on the incorporation of 3 H-thymidine into DNA of human neoplastic tissue. Natl Cancer Inst Monogr. 1971 Dec;34:197–203. [PubMed] [Google Scholar]
  8. Steel G. G., Adams K. Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res. 1975 Jun;35(6):1530–1535. [PubMed] [Google Scholar]
  9. Taylor D. M., Tew K. D., Jones J. D. Effects of cis-dichlorodiammine platinum (II) on DNA synthesis in kidney and other tissues of normal and tumour-bearing rats. Eur J Cancer. 1976 Apr;12(4):249–254. doi: 10.1016/0014-2964(76)90103-1. [DOI] [PubMed] [Google Scholar]
  10. Tisman G., Herbert V., Edlis H. Determination of therapeutic index of drugs by in vitro sensitivity tests using human host and tumor cell suspensions. Cancer Chemother Rep. 1973 Feb;57(1):11–19. [PubMed] [Google Scholar]
  11. Wheeler T. K., Dendy P. P., Dawson A. Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology. 1974;30(5):362–376. doi: 10.1159/000224977. [DOI] [PubMed] [Google Scholar]
  12. Wolberg W. H. Biochemical approaches to prediction of response in solid tumors. Natl Cancer Inst Monogr. 1971 Dec;34:189–195. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES